Doctronic navigation menu Log In
Doctronic navigation menu

Contents
  • How TKIs Work
  • Types of TKIs
  • Life on TKI Treatment

Revolutionizing CML Treatment: How Tyrosine Kinase Inhibitors Are Changing Lives

Revolutionizing CML Treatment: How Tyrosine Kinase Inhibitors Are Changing Lives

A Game-Changer in Cancer Care

Tyrosine Kinase Inhibitors (TKIs) have transformed Chronic Myeloid Leukemia (CML) from a life-threatening disease to a manageable chronic condition. These targeted drugs attack the root cause of CML, offering patients a chance at long-term survival.
Contents
  • How TKIs Work
  • Types of TKIs
  • Life on TKI Treatment

How TKIs Work

TKIs target the BCR-ABL1 protein, which is responsible for the uncontrolled cell growth in CML. By blocking this protein's activity, TKIs stop the production of abnormal white blood cells. It's like cutting off the fuel supply to a runaway train, bringing the disease under control.

Types of TKIs

There are several TKIs available for CML treatment, including imatinib, nilotinib, dasatinib, bosutinib, and ponatinib. Each drug has its own profile of effectiveness and side effects. Doctors choose the most appropriate TKI based on the patient's specific situation, including the phase of CML, other health conditions, and genetic factors.
TKIs are targeted drugs used in the treatment of Chronic Myeloid Leukemia, blocking the BCR-ABL1 protein to halt abnormal white blood cell production.

Life on TKI Treatment

TKI treatment is typically long-term, often lifelong. Most patients take their medication daily as pills. Regular check-ups and blood tests are necessary to monitor the treatment's effectiveness and watch for side effects. Many patients on TKIs lead normal lives, with some even achieving treatment-free remission after years of successful therapy.

FAQs

Do TKIs cure CML?

While not a cure, TKIs can control CML long-term in many patients.

What are common side effects?

Common side effects include fatigue, nausea, and muscle cramps, but vary by drug.

How long does TKI treatment last?

TKI treatment is often lifelong, but some patients achieve treatment-free remission.

Can I stop taking TKIs if I feel better?

Never stop TKIs without your doctor's guidance; CML can return quickly.

A Bright Future

TKIs have given CML patients hope for a normal lifespan and good quality of life.
Considering TKI treatment or have questions about managing CML? Reach out to Doctronic for personalized information and support.
Additional References
  1. Bower H, Björkholm M, Dickman PW, et al. Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population. J Clin Oncol 2016; 34:2851.
  2. Gambacorti-Passerini C, Antolini L, Mahon FX, et al. Multicenter independent assessment of outcomes in chronic myeloid leukemia patients treated with imatinib. J Natl Cancer Inst 2011; 103:553.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic.